(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

M C T META CELL TECHNOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

M C T META CELL TECHNOLOGY

ST13

US500000079428754

Class

10

Filing

79428754

Registration

8190983

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

06/30/2026

Trademark type

Combined

Nice classes

10

Filing date

05/28/2025

Registration date

03/31/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/31/2026

Last transaction

06/30/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

ES

Examiner

BARRETT, LEAH N

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the black letters "M," "C," and "T" in a stylized bold font. There is a small gray dot between the "M" and the "C," and a beige droplet between the 'C' and the "T." The wording "META CELL TECHNOLOGY" is depicted in black below these letters.

Holders and representatives

Holders

M. S. (pessoa física)

Representatives

Merce Hernandez Gazquez CURELL SUÑOL, SLP

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Fluid collection containers for medical use andin particularcontainers for ex-vivo treatment of biological liquids; containers for transporting samples containing living human cells; containers for applying medicines in the nature of syringesbagstubes and bottles; medical devices for activating biomaterials in the nature of cellsexosomes and platelet-rich plasma stimulation apparatus; medical biostimulation devices in the nature of cellsexosomes and platelet-rich plasma stimulation apparatus.

Publications

History of USPTO decisions and trademark events.

28 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/30/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/31/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/31/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/10/2026

PUBO

PUBLISHED FOR OPPOSITION

02/10/2026

GPNX

NOTIFICATION PROCESSED BY IB

02/05/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/04/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/21/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/20/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/13/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/13/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/13/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/13/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/29/2025

GNRT

NON-FINAL ACTION E-MAILED

12/29/2025

CNRT

NON-FINAL ACTION WRITTEN

12/29/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/19/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/19/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/19/2025

RFNT

REFUSAL PROCESSED BY IB

12/18/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/04/2025

RFRR

REFUSAL PROCESSED BY MPU

12/04/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/22/2025

CNRT

NON-FINAL ACTION WRITTEN

10/21/2025

DOCK

ASSIGNED TO EXAMINER

10/15/2025

MAFR

APPLICATION FILING RECEIPT MAILED

08/01/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/01/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/24/2025

Continuous trademark protection

Get notified about every new filing that threatens M C T META CELL TECHNOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.